Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades

被引:136
作者
Moss, KE [1 ]
Ioannou, Y [1 ]
Sultan, SM [1 ]
Haq, I [1 ]
Isenberg, DA [1 ]
机构
[1] UCL, Ctr Rheumatol, Dept Med, Bloomsbury Rheumatol Unit, London W1P 9PG, England
关键词
D O I
10.1136/ard.61.5.409
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine the mortality rate and causes of death in a cohort of 300 patients with systemic lupus erythematosus (SLE). Methods: A retrospective analysis was performed on all patients attending the SLE clinic between 1978 and 2000. Information was obtained on those patients lost to follow up. Cause of death was analysed and categorised as early (<5 years after diagnosis of SLE) and late (>5 years after diagnosis of SLE). Standardised mortality rates were obtained. Results: The patients were followed up for a median of 8.3 years. Seventy three (24%) patients were. no longer followed up at the end of the study period, of whom 41 (14%) had died. Of the 32 patients.. lost to follow up, 14 were being actively followed up within the UK, 16 were followed up outside the UK, and two patients were untraceable. The most common cause of death was malignancy, which accounted for eight (20%) deaths, followed by infection and vascular disease, which accounted for seven deaths each. (17%) Conclusions: Malignancy was the most common cause of death. Cause of death varied depending on disease duration. Forty per cent of early deaths were due to SLE related renal disease, whereas 23% of late deaths were due to vascular causes. Death due to infection occurred throughout the follow up period. There was a fourfold increased risk of death in our cohort of patients with SLE compared with the general population.
引用
收藏
页码:409 / 413
页数:5
相关论文
共 33 条
[1]  
ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259
[2]  
ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1265
[3]   CARDIOVASCULAR MANIFESTATIONS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - PROSPECTIVE-STUDY OF 100 PATIENTS [J].
BADUI, E ;
GARCIARUBI, D ;
ROBLES, E ;
JIMENEZ, J ;
JUAN, L ;
DELEZE, M ;
DIAZ, A ;
MINTZ, G .
ANGIOLOGY, 1985, 36 (07) :431-441
[4]  
BHALLA R, 1993, J RHEUMATOL, V20, P1316
[5]   IMMUNOPATHOLOGY OF CARDIAC LESIONS IN FATAL SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BIDANI, AK ;
ROBERTS, JL ;
SCHWARTZ, MM ;
LEWIS, EJ .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (06) :849-858
[6]  
Breslow NE, 1987, STAT METHODS CANC RE, VII
[7]  
DRENKARD C, 1994, J RHEUMATOL, V21, P1067
[8]  
GARDNER MJ, 1989, STAT CONFIDENCE
[9]   A MULTI-CENTER STUDY OF OUTCOME IN SYSTEMIC LUPUS-ERYTHEMATOSUS .1. ENTRY VARIABLES AS PREDICTORS OF PROGNOSIS [J].
GINZLER, EM ;
DIAMOND, HS ;
WEINER, M ;
SCHLESINGER, M ;
FRIES, JF ;
WASNER, C ;
MEDSGER, TA ;
ZIEGLER, G ;
KLIPPEL, JH ;
HADLER, NM ;
ALBERT, DA ;
HESS, EV ;
SPENCERGREEN, G ;
GRAYZEL, A ;
WORTH, D ;
HAHN, BH ;
BARNETT, EV .
ARTHRITIS AND RHEUMATISM, 1982, 25 (06) :601-611